Cytolysin-positive Enterococcus faecalis is not increased in patients with non-alcoholic steatohepatitis

Liver Int. 2020 Apr;40(4):860-865. doi: 10.1111/liv.14377. Epub 2020 Jan 23.

Abstract

Several studies show associations between gut bacterial dysbiosis and chronic liver diseases, but causative mechanisms are largely unclear. We recently identified cytolysin, a bacterial exotoxin expressed and secreted by Enterococcus faecalis to cause liver damage in the setting of alcohol-related liver disease. Cytolysin was increased and highly correlated with liver disease severity and mortality in alcoholic hepatitis patients. In this study, we investigated if faecal cytolysin-positivity can be linked to non-alcoholic fatty liver disease, a highly prevalent disease where new biomarkers and treatment targets are urgently needed. In contrast to what we observed in alcoholic hepatitis, only seven out of 96 non-alcoholic fatty liver disease patients were cytolysin-positive, and these patients did not have increased liver disease activity compared with cytolysin-negative patients. These results indicate that the association of cytolysin carriage with worse clinical outcome might be specific for alcoholic hepatitis.

Keywords: microbiome; microbiota; virulence factors.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cytotoxins
  • Dysbiosis
  • Enterococcus faecalis
  • Hepatitis, Alcoholic*
  • Humans
  • Non-alcoholic Fatty Liver Disease*

Substances

  • Cytotoxins